Prospects for Biological Cardiac Pacemaker Systems

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 11, 2003, Pages 2069-2071

  Ruhparwar, Arjang ^a,b   Haverich, Axel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Div Thorac and Cardiovasc Surg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA 2 ADRENERGIC RECEPTOR; BETA GALACTOSIDASE; CONNEXIN 40; CONNEXIN 43; GROWTH FACTOR; ISOPRENALINE; NEU DIFFERENTIATION FACTOR; POTASSIUM CHANNEL;

ADOPTIVE IMMUNOTHERAPY; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CATHETER ABLATION; CELL REGENERATION; CELL TRANSPLANTATION; ECONOMIC ASPECT; EDITORIAL; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; EMBRYO CELL; EMBRYO DEVELOPMENT; ENZYME INHIBITION; GAP JUNCTION; GENE THERAPY; GENE TRANSFER; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE CONDUCTION SYSTEM; HEART PACING; HORMONAL THERAPY; NONHUMAN; QRS COMPLEX; SINUS NODE; SINUS RHYTHM; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

ANIMALS; ARRHYTHMIA; CELL TRANSPLANTATION; FETAL TISSUE TRANSPLANTATION; GENE THERAPY; HEART CONDUCTION SYSTEM; HUMANS; MYOCARDIUM; NEUREGULIN-1; PACEMAKER, ARTIFICIAL;

EID: 0242636818     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.00322.x     Document Type: Editorial

References (18)

1. Brown HF. Electrophysiology of the sinoatrial node. Physiol Rev 1982; 62:505.
2. Slotwiner DJ, Stein KM, Markowitz SM, et al. Emerging indications for cardiac pacing. Heart Dis 2001; 3:224-230.
3. Friedman RA, Fenrich AL, Kertesz NJ. Congenital complete atrioventricular block Pacing Clin Electrophysiol 2001; 24:1681-1688.
4. Kusomoto FM, Goldschlager N. Cardiac pacing. N Engl J Med 1996; 334:1476-1477.
5. Steinhoff G, Stock U, Karim N, et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: In vivo restoration of valve tissue. Circulation 2000; 102(19 Suppl 3): III50-55.
6. Gillis AM. The impact of pulse generator longevity on the long-term costs of cardiac pacing. Pacing Clin Electrophysiol 1996; 10:1459-1468.
7. Ruhparwar A, Tebbenjohanns J, Niehaus M, et al. Transplanted fetal cardiomyocytes as cardiac pacemaker. Eur J Cardiothor Surg 2002; 21:853-857.
8. Beyer EC, Paul DL, Goodenough DA. Connexin 43: A protein from rat heart homologous to a gap junction protein from liver. J Cell Biol 1987; 105:2621-2629.
9. Abi-Gerges N, Ji GJ, Lu ZJ, et al. Functional expression and regulation of the hyperpolarization activated nonselective cation current in embryonic stem cell-derived cardiomyocytes. J Physiol 2000; 523:377-389.
10. Klug MG, Soonpaa MH, Koh GY, et al. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 1996; 98:216-224.
11. Muller M, Fleischmann BK, Selbert S, et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 2000; 14:2540-2548.
12. Nuss HB, Johns DC, Kaab S, et al. Reversal of potassium channel deficiency in cells from failing hearts by adenoviral'gene transfer: A prototype for gene therapy for disorders of cardiac excitability and contractility. Gene Ther 1996; 10:900-912.
13. Zipes DP, Wellens HJJ, Sudden cardiac death. Circulation 1998; 98:2334-2351.
14. Akhter SA, Skaer CA, Kypson AP, et al. Restoration of β-adrenergic signaling in failing cardiac ventricular cardiomyocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sci 1997; 94:12100-12105.
15. Miake J, Marban E, Nuss HB. Gene therapy: Biological pacemaker created by gene transfer. Nature 2002; 419:132-133.
16. Rentschler S, Zander J, Meyers K, et al. Neuregulin-1 promotes formation of the murine cardiac conduction system. PNAS 2002; 16:10464-10469.
17. Meyer D, Birchmeir C. Multiple essential functions of Neuregulin in development. Nature 1995; 378:386-390.
18. Rentschler S, Vaidya DM, Tamaddon H et al. Visualization and functional characterization of the developing murine cardiac conduction system. Development 2001; 128:1785-1792.